Achillion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ACHN and buy or sell other stocks, ETFs, and their options commission-free!

About ACHN

Antiaging Quantum Living, Inc. engages in the provision of online advertising services. The firm offers services with a focus on website development, maintenance, and promotion. 

CEO
Barry Wan
CEOBarry Wan
Employees
3
Employees3
Headquarters
Flushing, New York
HeadquartersFlushing, New York
Founded
2014
Founded2014
Employees
3
Employees3

ACHN Key Statistics

Market cap
231.70M
Market cap231.70M
Price-Earnings ratio
-17.95
Price-Earnings ratio-17.95
Dividend yield
Dividend yield
Average volume
211.20
Average volume211.20
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.56
52 Week high$2.56
52 Week low
$0.551
52 Week low$0.551

Stock Snapshot

With a market cap of 231.7M, Achillion Pharmaceuticals(ACHN) trades at $6.76. The stock has a price-to-earnings ratio of -17.95.

On 2026-08-21, Achillion Pharmaceuticals(ACHN) stock opened at —, reached a high of —, and a low of —.

The Achillion Pharmaceuticals(ACHN)'s current trading volume is 0, compared to an average daily volume of 211.2.

During the past year, Achillion Pharmaceuticals(ACHN) stock moved between $0.55 at its lowest and $2.56 at its peak.

During the past year, Achillion Pharmaceuticals(ACHN) stock moved between $0.55 at its lowest and $2.56 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.